Peter Kojo Quashie
ASSOCIATE PROFESSOR
CollegeCOLLEGE OF BASIC & APPLIED SC.
School / InstituteCOLLEGE OF BASIC & APPLIED SC.
DepartmentWEST AFRICAN CENTRE FOR CELL BIOLOGY OF INFECTIOUS PATHOGENS
Virology
Publication activity
Publication statistics
Publications
114 matching publications
| Publication | Year | Journal | Thematic area | Citations |
|---|---|---|---|---|
| Characterization of the R263K mutation in HIV-1 integrase that confers low-level resistance to the second-generation integrase strand transfer inhibitor dolutegravir PK Quashie, T Mesplède, YS Han, M Oliveira, DN Singhroy, T Fujiwara, ... |
2012 | Journal of virology 86 (5), 2696-2705, 2012 | Health Sciences | 289 |
| A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa E Wilkinson, M Giovanetti, H Tegally, JE San, R Lessells, D Cuadros, ... |
2021 | Science 374 (6566), 423-431, 2021 | Natural Sciences | 269 |
| The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance H Tegally, JE San, M Cotten, M Moir, B Tegomoh, G Mboowa, DP Martin, ... |
2022 | Science 378 (6615), eabq5358, 2022 | Natural Sciences | 225 |
| Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure T Mesplède, PK Quashie, N Osman, Y Han, DN Singhroy, Y Lie, ... |
2013 | Retrovirology 10 (1), 22, 2013 | Health Sciences | 157 |
| Evolution of HIV integrase resistance mutations PK Quashie, T Mesplède, MA Wainberg |
2013 | Current opinion in infectious diseases 26 (1), 43-49, 2013 | Health Sciences | 125 |
| Compensation by the E138K mutation in HIV-1 reverse transcriptase for deficits in viral replication capacity and enzyme processivity associated with the M184I/V mutations HT Xu, EL Asahchop, M Oliveira, PK Quashie, Y Quan, BG Brenner, ... |
2011 | Journal of virology 85 (21), 11300-11308, 2011 | Health Sciences | 122 |
| Recommendations for empowering early career researchers to improve research culture and practice BA Kent, C Holman, E Amoako, A Antonietti, JM Azam, H Ballhausen, ... |
2022 | PLoS Biology 20 (7), e3001680, 2022 | Natural Sciences | 118 |
| Novel therapeutic strategies targeting HIV integrase PK Quashie, RD Sloan, MA Wainberg |
2012 | BMC medicine 10 (1), 34, 2012 | Health Sciences | 97 |
| Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase PK Quashie, M Oliviera, T Veres, N Osman, YS Han, S Hassounah, Y Lie, ... |
2015 | Journal of virology 89 (6), 3163-3175, 2015 | Health Sciences | 95 |
| The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness M Wares, T Mesplède, PK Quashie, N Osman, Y Han, MA Wainberg |
2014 | Retrovirology 11 (1), 7, 2014 | Health Sciences | 94 |
| The development of novel HIV integrase inhibitors and the problem of drug resistance MA Wainberg, T Mesplède, PK Quashie |
2012 | Current opinion in virology 2 (5), 656-662, 2012 | Health Sciences | 82 |
| Automethylation of protein arginine methyltransferase 6 (PRMT6) regulates its stability and its anti-HIV-1 activity DN Singhroy, T Mesplède, A Sabbah, PK Quashie, JP Falgueyret, ... |
2013 | Retrovirology 10 (1), 73, 2013 | Health Sciences | 75 |
| Biochemical analysis of the role of G118R-linked dolutegravir drug resistance substitutions in HIV-1 integrase PK Quashie, T Mesplède, YS Han, T Veres, N Osman, S Hassounah, ... |
2013 | Antimicrobial agents and chemotherapy 57 (12), 6223-6235, 2013 | Health Sciences | 74 |
| Resistance to HIV integrase inhibitors T Mesplède, PK Quashie, MA Wainberg |
2012 | Current opinion in HIV and AIDS 7 (5), 401-408, 2012 | Health Sciences | 72 |
| Resistance mutations against dolutegravir in HIV integrase impair the emergence of resistance against reverse transcriptase inhibitors M Oliveira, T Mesplede, PK Quashie, D Moïsi, MA Wainberg |
2014 | Aids 28 (6), 813-819, 2014 | Health Sciences | 71 |
| Genetic diversity of SARS-CoV-2 infections in Ghana from 2020-2021 CM Morang’a, JM Ngoi, J Gyamfi, DSY Amuzu, BD Nuertey, PM Soglo, ... |
2022 | Nature Communications 13 (1), 2494, 2022 | Natural Sciences | 62 |
| Addition of E138K to R263K in HIV integrase increases resistance to dolutegravir, but fails to restore activity of the HIV integrase enzyme and viral replication capacity T Mesplede, N Osman, M Wares, PK Quashie, S Hassounah, K Anstett, ... |
2014 | Journal of Antimicrobial Chemotherapy 69 (10), 2733-2740, 2014 | Health Sciences | 59 |
| Integrase strand transfer inhibitors in the management of HIV-positive individuals T Mesplède, PK Quashie, V Zanichelli, MA Wainberg |
2014 | Annals of medicine 46 (3), 123-129, 2014 | Health Sciences | 57 |
| HIV drug resistance and the advent of integrase inhibitors PK Quashie, T Mesplède, MA Wainberg |
2013 | Current infectious disease reports 15 (1), 85-100, 2013 | Health Sciences | 57 |
| Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistance I Hardy, B Brenner, P Quashie, R Thomas, C Petropoulos, W Huang, ... |
2015 | Journal of Antimicrobial Chemotherapy 70 (2), 405-411, 2015 | Health Sciences | 52 |
| The COVID-19, tuberculosis and HIV/AIDS: Ménage à Trois AJ Udoakang, AL Djomkam Zune, K Tapela, NN Nganyewo, FN Olisaka, ... |
2023 | Frontiers in immunology 14, 1104828, 2023 | Health Sciences | 51 |
| Identification of a pyridoxine-derived small-molecule inhibitor targeting dengue virus RNA-dependent RNA polymerase HT Xu, SP Colby-Germinario, S Hassounah, PK Quashie, Y Han, ... |
2016 | Antimicrobial agents and chemotherapy 60 (1), 600-608, 2016 | Health Sciences | 47 |
| Detection of SARS-CoV-2 intra-host recombination during superinfection with Alpha and Epsilon variants in New York City JO Wertheim, JC Wang, M Leelawong, DP Martin, JL Havens, ... |
2022 | Nature communications 13 (1), 3645, 2022 | Natural Sciences | 46 |
| Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana PK Quashie, JK Mutungi, F Dzabeng, D Oduro-Mensah, PC Opurum, ... |
2026 | Wellcome Open Research 6, 173, 2026 | Health Sciences | 39 |
| Genomic analysis of SARS-CoV-2 reveals local viral evolution in Ghana JM Ngoi, PK Quashie, CM Morang'a, JHK Bonney, DSY Amuzu, ... |
2021 | Experimental Biology and Medicine 246 (8), 960-970, 2021 | Health Sciences | 38 |